Phase 1 Thyroid Eye Disease (TED) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Clinical Study of Cizutamig in Thyroid Eye Disease

Thyroid Eye Disease (TED)

Candid Therapeutics38 enrolled1 locationNCT07597200

Recruiting

Phase 1

A Study of GenSci098 in Subjects With Active Thyroid Eye Disease

SafetyTolerabilityGenSci098+1 more

Changchun GeneScience Pharmaceutical Co., Ltd.76 enrolled1 locationNCT06569758